|
13 Sep 2025 |
ICICI Bank
|
Consensus Share Price Target
|
1417.70 |
1682.92 |
- |
18.71 |
buy
|
|
|
|
|
28 Jul 2024
|
ICICI Bank
|
Edelweiss
|
1417.70
|
1430.00
|
1207.20
(17.44%)
|
Target met |
Buy
|
|
|
Well begun is half done
|
|
28 Jul 2024
|
ICICI Bank
|
Prabhudas Lilladhar
|
1417.70
|
1520.00
|
1207.20
(17.44%)
|
|
Buy
|
|
|
|
|
28 Jul 2024
|
ICICI Bank
|
Motilal Oswal
|
1417.70
|
1400.00
|
1207.20
(17.44%)
|
Target met |
Buy
|
|
|
ICICIBC reported a steady quarter, with 15% YoY growth in net earnings (4% beat).
|
|
27 Jul 2024
|
ICICI Bank
|
Sharekhan
|
1417.70
|
1450.00
|
1207.20
(17.44%)
|
Target met |
Buy
|
|
|
Core earnings were broadly in line but reported earnings were above estimates mainly led by higher treasury gains and other income which resulted in steady state RoA at ~2.36%.
|
|
02 May 2024
|
ICICI Bank
|
BOB Capital Markets Ltd.
|
1417.70
|
1272.00
|
1139.45
(24.42%)
|
Target met |
Hold
|
|
|
NII grew 2%/8% QoQ/YoY due to moderation in credit growth, while PAT grew 4%/17% QoQ /YoY supported by lower opex and provision
|
|
29 Apr 2024
|
ICICI Bank
|
IDBI Capital
|
1417.70
|
1375.00
|
1160.15
(22.20%)
|
Target met |
Buy
|
|
|
|
|
29 Apr 2024
|
ICICI Bank
|
Edelweiss
|
1417.70
|
1330.00
|
1160.15
(22.20%)
|
Target met |
Buy
|
|
|
Fulfils expectations, plenty levers for growth
|
|
29 Apr 2024
|
ICICI Bank
|
SMC online
|
1417.70
|
|
1160.15
(22.20%)
|
|
Results Update
|
|
|
|
|
29 Apr 2024
|
ICICI Bank
|
Axis Direct
|
1417.70
|
1325.00
|
1160.15
(22.20%)
|
Target met |
Buy
|
|
|
We reiterate our BUY recommendation, valuing the stock at 2.8x Sep'25E ABV (vs current valuation of 2.7x Sep'25E ABV), its core book and a subsidiary value of Rs 185/share, to arrive at a target price of Rs 1,325/share. The TP implies an upside sof 20% from the CMP.
|
|
28 Apr 2024
|
ICICI Bank
|
Motilal Oswal
|
1417.70
|
1300.00
|
1107.90
(27.96%)
|
Target met |
Buy
|
|
|
ICICI Bank (ICICIBC) reported a healthy performance in 4QFY24, with 17% YoY growth in net earnings (in line) amid contained opex and provisions. The pace of NIM contraction decelerated, down 3bp QoQ at 4.4% (vs. - 10bp in 3Q).
|